Skip to main content
Premium Trial:

Request an Annual Quote

Eppendorf Acquires Belgian Microarray Company

¡NEW YORK, July 19-The Hamburg biotech tool firm Eppendorf AG has acquired a majority interest in the Belgian microarray company Advanced Array Technology, the company said yesterday.


Eppendorf plans to introduce its first microarrays from this line before the end of 2002. In 2003, the company plans to launch additional biochips as well as instruments for processing and analysis.


The acquisition marks a move into microarrays for the lab equipment and supply giant.


Advanced Array Technology was spun off from the University of Namur in 1999. The company focuses on developing biochips and transcription factor detection kits. It currently has 15 employees.


The new unit is called Eppendorf Array Technologies, and is led by José Remacle, a microarray scientist with the Faculté Universitaires Notre Dame de la Paix in Namur, Belgium.

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.